Compare GWRE & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GWRE | FMS |
|---|---|---|
| Founded | 2001 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 13.6B |
| IPO Year | 2011 | 2005 |
| Metric | GWRE | FMS |
|---|---|---|
| Price | $175.59 | $23.77 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 14 | 2 |
| Target Price | ★ $251.31 | $30.00 |
| AVG Volume (30 Days) | ★ 1.2M | 750.5K |
| Earning Date | 06-02-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | ★ 1257.14 | N/A |
| EPS | ★ 1.26 | N/A |
| Revenue | ★ $719,514,000.00 | N/A |
| Revenue This Year | $22.67 | N/A |
| Revenue Next Year | $15.73 | $3.83 |
| P/E Ratio | $144.94 | ★ $15.62 |
| Revenue Growth | ★ 8.84 | N/A |
| 52 Week Low | $102.30 | $20.02 |
| 52 Week High | $272.60 | $27.64 |
| Indicator | GWRE | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 63.96 | 44.85 |
| Support Level | $121.28 | $23.51 |
| Resistance Level | $226.57 | $23.91 |
| Average True Range (ATR) | 8.15 | 0.50 |
| MACD | 1.63 | -0.18 |
| Stochastic Oscillator | 75.50 | 10.57 |
Guidewire Software provides cloud-based software solutions for property and casualty insurers. The flagship product, InsuranceSuite is a system of record and comprises ClaimCenter, a claims management system; PolicyCenter, a policy management system including policy definitions, quotas, issuance, maintenance, and renewal; and BillingCenter, for billing management, payment plans, and agent commissions. The company also offers InsuranceNow, a midmarket offering, as well as a variety of other add-on applications and services.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.